352 results on '"Pose, Elisa"'
Search Results
2. Liver fibrosis screening increases alcohol abstinence
3. Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis
4. Renal Complications in Portal Hypertension
5. Hepatorenal Syndrome in Cirrhosis
6. Alcoholic Foamy Degeneration, an Entity Resembling Alcohol-Associated Hepatitis: Diagnosis, Prognosis, and Molecular Profiling
7. Alcohol-associated liver disease: Epidemiology and management
8. Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients
9. Adding Inflammatory Markers and Refining National Institute on Alcohol Abuse and Alcoholism Criteria Improve Diagnostic Accuracy for Alcohol-associated Hepatitis
10. Therapeutic targeting of adipose tissue macrophages ameliorates liver fibrosis in non-alcoholic fatty liver disease
11. Ductular reaction-associated neutrophils promote biliary epithelium proliferation in chronic liver disease
12. Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study
13. Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogramming
14. Global burden of liver disease: 2023 update
15. Molecular characterization of chronic liver disease dynamics: From liver fibrosis to acute-on-chronic liver failure
16. The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
17. Renal Replacement Therapy for Acute Kidney Injury in Severe Alcohol-Associated Hepatitis as a Bridge to Transplant or Recovery
18. WED-155 A ratio of exchangeable copper below 15% accurately excludes Wilson disease and may be useful for the first-line ethiologic work-up within a liver unit
19. TOP-241-YI Longitudinal changes in liver stiffness measurements in a population-based screening cohort of 5, 517 participants
20. WED-284-YI The Fatty Liver Index (FLI) is more accurate than FIB-4 for detection of advanced liver fibrosis in patients with type-2 Diabetes Mellitus (T2DM) in Primary Care
21. THU-056 Soluble PD-L1 levels as predictors of ACLF in decompensated cirrhosis: findings from two independent cohorts
22. OS-005-YI Single-cell RNA sequencing analysis in alcohol-related liver disease identifies specific cell subpopulations characterized by an inflammatory profile in alcohol-associated hepatitis
23. WED-055 Effect of long-term treatment with Simvastatin and Rifaximin in mitochondrial and proinflammatory pathways in patients with decompensated cirrhosis. A single-cell RNA seq analysis in PBMCs
24. SAT-267 The interaction between metabolic syndrome and alcohol consumption after an episode of alcohol-associated hepatitis is associated with increased mortality: results from de spanish registry of alcohol-associated liver disease (REHALC)
25. SAT-257 Hepatorenal syndrome markedly impacts prognosis of patients with alcohol-associated hepatitis. Results from the spanish registry of alcohol-associated liver disease (REHALC)
26. Hyperkalemia influences the outcome of patients with cirrhosis with acute decompensation (AD) and acute-on-chronic liver failure (ACLF)
27. Profiling circulating microRNAs in patients with cirrhosis and acute-on-chronic liver failure
28. Endothelial dysfunction markers predict short-term mortality in patients with severe alcoholic hepatitis
29. Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and Prognosis
30. Population screening for cirrhosis.
31. Binge drinking at time of bariatric surgery is associated with liver disease, suicides, and increases long-term mortality.
32. Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial
33. Multiplatform web app (My Way Up) plus motivational interviewing for improving treatment retention in patients with onset of alcohol-related liver disease and alcohol use disorder – an example of participatory research
34. Statins: Old drugs as new therapy for liver diseases?
35. NAFLD Gets Renamed as MASLD: Progress but with Challenges
36. Reply: Medications promoting abstinence in alcohol-related cirrhosis
37. Alcohol-associated liver disease: epidemiology and management.
38. Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial
39. Defining recompensation of alcohol‐related liver disease: A step beyond decompensated cirrhosis
40. Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study
41. Medications for alcohol use disorder promote abstinence in alcohol-associated cirrhosis: Results from a systematic review and meta-analysis
42. Validation of a Staging System for Acute Kidney Injury in Patients With Cirrhosis and Association With Acute-on-Chronic Liver Failure
43. Nonalcoholic Fatty Liver Disease Gets Renamed as Metabolic Dysfunction–Associated Steatotic Liver Disease: Progress But With Challenges.
44. Medications for alcohol use disorder promote abstinence in alcohol-associated cirrhosis: Results from a systematic review and meta-analysis.
45. Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis.
46. 3,5-Diethoxycarbonyl-1,4-Dihydrocollidine Diet: A Rodent Model in Cholestasis Research
47. Psychological Burden of Hepatic Encephalopathy on Patients and Caregivers
48. Patients with alcohol-related cirrhosis who recompensate on follow-up have a characteristic metabolomic profile with differential concentrations of lipid and amino-acid metabolites
49. Recompensation following an episode of alcohol-associated hepatitis mostly occurs in the first year of follow-up and is related to Child-Pugh score, levels of GGT and platelets, and alcohol abstinence
50. Beneficial effects of a screening programme for alcohol-related liver fibrosis with transient elastography in people with alcohol use disorder promoting alcohol abstinence
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.